Meningococcal Vaccines Market Size, Share & Trends Report

Meningococcal Vaccines Market (2026 - 2033) Size, Share & Trends Analysis Report By Type (Bivalent, Quadrivalent), By Brand (Menveo, Menactra, Nimenrix, Trumenba), By Serotype (W-135), By Age Group (Infants (0 to 2 years), By Sales Channel, By Region, And Segment Forecasts

Market Segmentation

Meningococcal Vaccines Type Outlook (Revenue, USD Million, 2021 - 2033)
- Bivalent
- Quadrivalent
- Others
Meningococcal Vaccines Brand Outlook (Revenue, USD Million, 2021 - 2033)
- Menactra
- Menveo
- Nimenrix
- Trumenba
- Bexsero
- Others
Meningococcal Vaccines Serotype Outlook (Revenue, USD Million, 2021 - 2033)
- A
- B
- C
- W-135
- Y
Meningococcal Vaccines Age Group Outlook (Revenue, USD Million, 2021 - 2033)
- Infants (0 to 2 years)
- Children and Adults (2 years and above)
Meningococcal Vaccines Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Private
- Public
Meningococcal Vaccines Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Meningococcal Vaccines Market, By Type
    - Bivalent
    - Quadrivalent
    - Others
  - North America Meningococcal Vaccines Market, By Brand
    - Menactra
    - Menveo
    - Nimenrix
    - Trumenba
    - Bexsero
    - Others
  - North America Meningococcal Vaccines Market, By Serotype
    - A
    - B
    - C
    - W-135
    - Y
  - North America Meningococcal Vaccines Market, By Age Group
    - Infants (0 to 2 years)
    - Children and Adults (2 years and above)
  - North America Meningococcal Vaccines Market, By Sales Channel
    - Private
    - Public
  - U.S.
    - U.S. Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - U.S. Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - U.S. Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - U.S. Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - U.S. Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Canada
    - Canada Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Canada Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Canada Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Canada Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Canada Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Mexico
    - Mexico Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Mexico Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Mexico Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Mexico Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Mexico Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
- Europe
  - Europe Meningococcal Vaccines Market, By Type
    - Bivalent
    - Quadrivalent
    - Others
  - Europe Meningococcal Vaccines Market, By Brand
    - Menactra
    - Menveo
    - Nimenrix
    - Trumenba
    - Bexsero
    - Others
  - Europe Meningococcal Vaccines Market, By Serotype
    - A
    - B
    - C
    - W-135
    - Y
  - Europe Meningococcal Vaccines Market, By Age Group
    - Infants (0 to 2 years)
    - Children and Adults (2 years and above)
  - Europe Meningococcal Vaccines Market, By Sales Channel
    - Private
    - Public
  - UK
    - UK Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - UK Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - UK Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - UK Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - UK Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Germany
    - Germany Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Germany Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Germany Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Germany Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Germany Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - France
    - France Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - France Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - France Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - France Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - France Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Italy
    - Italy Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Italy Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Italy Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Italy Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Italy Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Spain
    - Spain Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Spain Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Spain Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Spain Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Spain Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Denmark
    - Denmark Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Denmark Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Denmark Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Denmark Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Denmark Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Sweden
    - Sweden Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Sweden Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Sweden Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Sweden Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Sweden Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Norway
    - Norway Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Norway Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Norway Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Norway Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Norway Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
- Asia Pacific
  - Asia Pacific Meningococcal Vaccines Market, By Type
    - Bivalent
    - Quadrivalent
    - Others
  - Asia Pacific Meningococcal Vaccines Market, By Brand
    - Menactra
    - Menveo
    - Nimenrix
    - Trumenba
    - Bexsero
    - Others
  - Asia Pacific Meningococcal Vaccines Market, By Serotype
    - A
    - B
    - C
    - W-135
    - Y
  - Asia Pacific Meningococcal Vaccines Market, By Age Group
    - Infants (0 to 2 years)
    - Children and Adults (2 years and above)
  - Asia Pacific Meningococcal Vaccines Market, By Sales Channel
    - Private
    - Public
  - Japan
    - Japan Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Japan Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Japan Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Japan Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Japan Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - China
    - China Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - China Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - China Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - China Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - China Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - India
    - India Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - India Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - India Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - India Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - India Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Australia
    - Australia Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Australia Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Australia Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Australia Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Australia Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - South Korea
    - South Korea Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - South Korea Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - South Korea Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - South Korea Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - South Korea Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Thailand
    - Thailand Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Thailand Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Thailand Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Thailand Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Thailand Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
- Latin America
  - Latin America Meningococcal Vaccines Market, By Type
    - Bivalent
    - Quadrivalent
    - Others
  - Latin America Meningococcal Vaccines Market, By Brand
    - Menactra
    - Menveo
    - Nimenrix
    - Trumenba
    - Bexsero
    - Others
  - Latin America Meningococcal Vaccines Market, By Serotype
    - A
    - B
    - C
    - W-135
    - Y
  - Latin America Meningococcal Vaccines Market, By Age Group
    - Infants (0 to 2 years)
    - Children and Adults (2 years and above)
  - Latin America Meningococcal Vaccines Market, By Sales Channel
    - Private
    - Public
  - Brazil
    - Brazil Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Brazil Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Brazil Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Brazil Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Brazil Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Argentina
    - Argentina Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Argentina Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Argentina Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Argentina Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Argentina Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
- Middle East & Africa
  - Middle East & Africa Meningococcal Vaccines Market, By Type
    - Bivalent
    - Quadrivalent
    - Others
  - Middle East & Africa Meningococcal Vaccines Market, By Brand
    - Menactra
    - Menveo
    - Nimenrix
    - Trumenba
    - Bexsero
    - Others
  - Middle East & Africa Meningococcal Vaccines Market, By Serotype
    - A
    - B
    - C
    - W-135
    - Y
  - Middle East & Africa Meningococcal Vaccines Market, By Age Group
    - Infants (0 to 2 years)
    - Children and Adults (2 years and above)
  - Middle East & Africa Meningococcal Vaccines Market, By Sales Channel
    - Private
    - Public
  - South Africa
    - South Africa Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - South Africa Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - South Africa Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - South Africa Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - South Africa Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Saudi Arabia
    - Saudi Arabia Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Saudi Arabia Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Saudi Arabia Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Saudi Arabia Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Saudi Arabia Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - UAE
    - UAE Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - UAE Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - UAE Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - UAE Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - UAE Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public
  - Kuwait
    - Kuwait Meningococcal Vaccines Market, By Type
      - Bivalent
      - Quadrivalent
      - Others
    - Kuwait Meningococcal Vaccines Market, By Brand
      - Menactra
      - Menveo
      - Nimenrix
      - Trumenba
      - Bexsero
      - Others
    - Kuwait Meningococcal Vaccines Market, By Serotype
      - A
      - B
      - C
      - W-135
      - Y
    - Kuwait Meningococcal Vaccines Market, By Age Group
      - Infants (0 to 2 years)
      - Children and Adults (2 years and above)
    - Kuwait Meningococcal Vaccines Market, By Sales Channel
      - Private
      - Public

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments